InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Litvack Frank, Director. Director active across 1 companies, notably Capricor Therapeutics, INC.. Cumulatively, 4 filings have been logged. The latest transaction was disclosed on 13 May 2026 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€4,6713,937 shares@ €1.18640.0003% mcap1.2% of flow
Common Stock
SEC:0001310715-26-000004:0·
€4,6713,937 shares@ €1.18642.4% of flow
Common Stock
SEC:0001310715-26-000004·
€188,874154,543 shares@ €1.222197.6% of flow
Common Stock
SEC:0001415889-22-000284·
€188,874154,543 shares@ €1.22210.011% mcap48.8% of flow
Common Stock
SEC:0001415889-22-000284:0·
4 of 4 declarations
About Litvack Frank
Frank Litvack is a Board Member of Capricor Therapeutics, Inc., a biotechnology company. As a board member, he participates in overseeing the company's activities and making strategic decisions. His expertise in the biotechnology field is valuable for guiding Capricor's initiatives.
